Biochemical principles and inhibitors to interfere with viral capping pathways

Current Opinion in Virology

Volumn 24, Issue , 2017, Pages 87-96

  Decroly, Etienne ^a   Canard, Bruno ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

5 ' RNA TRIPHOSPHATASE; CAP METHYLTRANSFERASE; ENDONUCLEASE; GUANYLYLTRANSFERASE; MESSENGER RNA; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS RNA; ACID ANHYDRIDE HYDROLASE; ANTIVIRUS AGENT; CAPPED RNA; ENZYME INHIBITOR; HYDROLASE; RNA TRIPHOSPHATASE; TRANSFERASE; VIRAL PROTEIN;

ALPHAVIRUS; BIOCHEMICAL ANALYSIS; CATALYSIS; CONFORMATIONAL TRANSITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REVIEW; RNA CAPPING; TOGAVIRIDAE; VIRUS INHIBITION; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; DNA REPLICATION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; MOLECULAR MODEL; PHYSIOLOGY; VIRUS; VIRUS REPLICATION;

ACID ANHYDRIDE HYDROLASES; ANIMALS; ANTIVIRAL AGENTS; DNA REPLICATION; ENDONUCLEASES; ENZYME INHIBITORS; HUMANS; HYDROLASES; MODELS, MOLECULAR; RNA CAPS; RNA, MESSENGER; RNA, VIRAL; TRANSFERASES; VIRAL PROTEINS; VIRUS REPLICATION; VIRUSES;

EID: 85019408529     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2017.04.003     Document Type: Review

References (60)

1. 1•• Ramanathan, A., Robb, G.B., Chan, S.-H., mRNA capping: biological functions and applications. Nucleic Acids Res. 44 (2016), 7511–7526 An extensive general review of the RNA capping field, including “alternate” caps, cytoplasmic capping/de-capping, and applications of RNA capping.
2. Leung, D.W., Amarasinghe, G.K., When your cap matters: structural insights into self vs non-self recognition of 5′ RNA by immunomodulatory host proteins. Curr. Opin. Struct. Biol. 36 (2016), 133–141.
3. Schuberth-Wagner, C., Ludwig, J., Bruder, A.K., Herzner, A.-M., Zillinger, T., Goldeck, M., Schmidt, T., Schmid-Burgk, J.L., Kerber, R., Wolter, S., et al. A conserved histidine in the RNA sensor RIG-I controls immune tolerance to N1-2′ O-methylated self RNA. Immunity 43 (2015), 41–51.
4. Züst, R., Cervantes-Barragan, L., Habjan, M., Maier, R., Neuman, B.W., Ziebuhr, J., Szretter, K.J., Baker, S.C., Barchet, W., Diamond, M.S., et al. Ribose 2′-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat. Immunol. 12 (2011), 137–143.
5. Daffis, S., Szretter, K.J., Schriewer, J., Li, J., Youn, S., Errett, J., Lin, T.-Y., Schneller, S., Zust, R., Dong, H., et al. 2′-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468 (2010), 452–456.
6. 6• Decroly, E., Ferron, F., Lescar, J., Canard, B., Conventional and unconventional mechanisms for capping viral mRNA. Nat. Rev. Microbiol. 10 (2011), 51–65 An extensive general review of viral RNA capping, useful in complementing Ref. [1].
7. Shuman, S., Hurwitz, J., Mechanism of mRNA capping by vaccinia virus guanylyltransferase: characterization of an enzyme–guanylate intermediate. Proc. Natl. Acad. Sci. U. S. A. 78 (1981), 187–191.
8. Håkansson, K., Doherty, A.J., Shuman, S., Wigley, D.B., X-ray crystallography reveals a large conformational change during guanyl transfer by mRNA capping enzymes. Cell 89 (1997), 545–553.
9. Cong, P., Shuman, S., Mutational analysis of mRNA capping enzyme identifies amino acids involved in GTP binding, enzyme–guanylate formation, and GMP transfer to RNA. Mol. Cell. Biol. 15 (1995), 6222–6231.
10. Niles, E.G., Christen, L., Identification of the vaccinia virus mRNA guanyltransferase active site lysine. J. Biol. Chem. 268 (1993), 24986–24989.
11. Kyrieleis, O.J.P., Chang, J., de la Peña, M., Shuman, S., Cusack, S., Crystal structure of vaccinia virus mRNA capping enzyme provides insights into the mechanism and evolution of the capping apparatus. Struct. Lond. Engl. 1993 22 (2014), 452–465.
12. Ray, D., Shah, A., Tilgner, M., Guo, Y., Zhao, Y., Dong, H., Deas, T.S., Zhou, Y., Li, H., Shi, P.-Y., West Nile virus 5′-cap structure is formed by sequential guanine N-7 and ribose 2′-O methylations by nonstructural protein 5. J. Virol. 80 (2006), 8362–8370.
13. Dong, H., Ren, S., Li, H., Shi, P.-Y., Separate molecules of West Nile virus methyltransferase can independently catalyze the N7 and 2′-O methylations of viral RNA cap. Virology 377 (2008), 1–6.
14. Bouvet, M., Debarnot, C., Imbert, I., Selisko, B., Snijder, E.J., Canard, B., Decroly, E., In vitro reconstitution of SARS-coronavirus mRNA cap methylation. PLoS Pathog., 6, 2010, e1000863.
15. Ogino, T., Banerjee, A.K., Unconventional mechanism of mRNA capping by the RNA-dependent RNA polymerase of vesicular stomatitis virus. Mol. Cell 25 (2007), 85–97.
16. Ahola, T., Kääriäinen, L., Reaction in alphavirus mRNA capping: formation of a covalent complex of nonstructural protein nsP1 with 7-methyl-GMP. Proc. Natl. Acad. Sci. U. S. A. 92 (1995), 507–511.
17. Li, Y.I., Chen, Y.J., Hsu, Y.H., Meng, M., Characterization of the AdoMet-dependent guanylyltransferase activity that is associated with the N terminus of bamboo mosaic virus replicase. J. Virol. 75 (2001), 782–788.
18. 18• Li, C., Guillén, J., Rabah, N., Blanjoie, A., Debart, F., Vasseur, J.-J., Canard, B., Decroly, E., Coutard, B., mRNA capping by Venezuelan equine encephalitis virus nsP1: functional characterization and implications for antiviral research. J. Virol. 89 (2015), 8292–8303 The first demonstration of actual transfer of the m7G cap onto acceptor RNA using a Togaviridae enzyme. Assays are described to un-couple reactions along the alphavirus-like capping pathway.
19. Dias, A., Bouvier, D., Crépin, T., McCarthy, A.A., Hart, D.J., Baudin, F., Cusack, S., Ruigrok, R.W.H., The cap-snatching endonuclease of influenza virus polymerase resides in the PA subunit. Nature 458 (2009), 914–918.
20. 20•• Reich, S., Guilligay, D., Pflug, A., Malet, H., Berger, I., Crépin, T., Hart, D., Lunardi, T., Nanao, M., Ruigrok, R.W.H., et al. Structural insight into cap-snatching and RNA synthesis by influenza polymerase. Nature 516 (2014), 361–366 A landmark paper of the crystal structure of the 3 subunit influenza polymerase presenting how RNA synthesis and RNA cap-snatching are physically coupled and coordinated.
21. Reguera, J., Weber, F., Cusack, S., Bunyaviridae RNA polymerases (L-protein) have an N-terminal, influenza-like endonuclease domain, essential for viral cap-dependent transcription. PLoS Pathog., 6, 2010, e1001101.
22. 22•• Reguera, J., Gerlach, P., Rosenthal, M., Gaudon, S., Coscia, F., Günther, S., Cusack, S., Comparative structural and functional analysis of bunyavirus and arenavirus cap-snatching endonucleases. PLoS Pathog., 12, 2016, e1005636 Structural, enzymatic, and evolutionary perspective of the ambisense RNA virus endonucleases, examined comparatively to that of the influenza virus. Although overall folding is conserved, active-site peculiarites and activities are compared and discussed.
23. Morin, B., Coutard, B., Lelke, M., Ferron, F., Kerber, R., Jamal, S., Frangeul, A., Baronti, C., Charrel, R., de Lamballerie, X., et al. The N-terminal domain of the arenavirus L protein is an RNA endonuclease essential in mRNA transcription. PLoS Pathog., 6, 2010, e1001038.
24. Changela, A., Martins, A., Shuman, S., Mondragón, A., Crystal structure of baculovirus RNA triphosphatase complexed with phosphate. J. Biol. Chem. 280 (2005), 17848–17856.
25. Benarroch, D., Smith, P., Shuman, S., Characterization of a trifunctional mimivirus mRNA capping enzyme and crystal structure of the RNA triphosphatase domain. Struct. Lond. Engl. 1993 16 (2008), 501–512.
26. 26• Smith, P., Ho, C.K., Takagi, Y., Djaballah, H., Shuman, S., Nanomolar inhibitors of Trypanosoma brucei RNA triphosphatase. mBio 7 (2016), e00058–00016 A HTS effort on a test library identifies compounds to inhibit the TTM triphosphatase in the nanomolar range, and thus validates this enzyme as an anti-infective target.
27. Sutton, G., Grimes, J.M., Stuart, D.I., Roy, P., Bluetongue virus VP4 is an RNA-capping assembly line. Nat. Struct. Mol. Biol. 14 (2007), 449–451.
28. Reinisch, K.M., Nibert, M.L., Harrison, S.C., Structure of the reovirus core at 3.6 Å resolution. Nature 404 (2000), 960–967.
29. Luo, D., Xu, T., Watson, R.P., Scherer-Becker, D., Sampath, A., Jahnke, W., Yeong, S.S., Wang, C.H., Lim, S.P., Strongin, A., et al. Insights into RNA unwinding and ATP hydrolysis by the flavivirus NS3 protein. EMBO J. 27 (2008), 3209–3219.
30. Luo, D., Vasudevan, S.G., Lescar, J., The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development. Antivir. Res. 118 (2015), 148–158.
31. Shuman, S., Schwer, B., RNA capping enzyme and DNA ligase: a superfamily of covalent nucleotidyl transferases. Mol. Microbiol. 17 (1995), 405–410.
32. Byszewska, M., Śmietański, M., Purta, E., Bujnicki, J.M., RNA methyltransferases involved in 5′ cap biosynthesis. RNA Biol. 11 (2014), 1597–1607.
33. Hodel, A.E., Gershon, P.D., Shi, X., Quiocho, F.A., The 1.85 Å structure of vaccinia protein VP39: a bifunctional enzyme that participates in the modification of both mRNA ends. Cell 85 (1996), 247–256.
34. Decroly, E., Debarnot, C., Ferron, F., Bouvet, M., Coutard, B., Imbert, I., Gluais, L., Papageorgiou, N., Sharff, A., Bricogne, G., et al. Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2′-O-methyltransferase nsp10/nsp16 complex. PLoS Pathog., 7, 2011, e1002059.
35. Chen, Y., Su, C., Ke, M., Jin, X., Xu, L., Zhang, Z., Wu, A., Sun, Y., Yang, Z., Tien, P., et al. Biochemical and structural insights into the mechanisms of SARS coronavirus RNA ribose 2′-O-methylation by nsp16/nsp10 protein complex. PLoS Pathog., 7, 2011, e1002294.
36. 36•• Paesen, G.C., Collet, A., Sallamand, C., Debart, F., Vasseur, J.-J., Canard, B., Decroly, E., Grimes, J.M., X-ray structure and activities of an essential Mononegavirales L-protein domain. Nat. Commun., 6, 2015, 8749 The first crystal structure of a NNS virus L protein with an associated functional study, revealing how the NTPase and bi-functional MTase are spatially organized, distinct from the yet unknown PNRTase domain.
37. 37•• Devarkar, S.C., Wang, C., Miller, M.T., Ramanathan, A., Jiang, F., Khan, A.G., Patel, S.S., Marcotrigiano, J., Structural basis for m7G recognition and 2′-O-methyl discrimination in capped RNAs by the innate immune receptor RIG-I. Proc. Natl. Acad. Sci. U. S. A. 113 (2016), 596–601 A structural and mechanistic basis for capping and 2′-O-methylation, and how it evades RIG-I recognition. The structure of RIG-I reveals how the H830 residue is crucial for discriminating between Cap-0 and Cap-1 RNAs.
38. Lim, S.P., Sonntag, L.S., Noble, C., Nilar, S.H., Ng, R.H., Zou, G., Monaghan, P., Chung, K.Y., Dong, H., Liu, B., et al. Small molecule inhibitors that selectively block dengue virus methyltransferase. J. Biol. Chem. 286 (2011), 6233–6240.
39. Coutard, B., Barral, K., Lichière, J., Selisko, B., Martin, B., Aouadi, W., Lombardia, M.O., Debart, F., Vasseur, J.-J., Guillemot, J.C., et al. Zika virus methyltransferase: structure and functions for drug design perspectives. J. Virol., 91, 2017.
40. Stephen, P., Baz, M., Boivin, G., Lin, S.-X., Structural insight into NS5 of Zika virus leading to the discovery of MTase inhibitors. J. Am. Chem. Soc. 138 (2016), 16212–16215.
41. Wang, Y., Sun, Y., Wu, A., Xu, S., Pan, R., Zeng, C., Jin, X., Ge, X., Shi, Z., Ahola, T., et al. Coronavirus nsp10/nsp16 methyltransferase can be targeted by nsp10-derived peptide in vitro and in vivo to reduce replication and pathogenesis. J. Virol. 89 (2015), 8416–8427.
42. De Clercq, E., Cools, M., Balzarini, J., Marquez, V.E., Borcherding, D.R., Borchardt, R.T., Drach, J.C., Kitaoka, S., Konno, T., Broad-spectrum antiviral activities of neplanocin A, 3-deazaneplanocin A, and their 5′-nor derivatives. Antimicrob. Agents Chemother. 33 (1989), 1291–1297.
43. Bray, M., Raymond, J.L., Geisbert, T., Baker, R.O., 3-Deazaneplanocin A induces massively increased interferon-alpha production in Ebola virus-infected mice. Antivir. Res. 55 (2002), 151–159.
44. De Clercq, E., Ebola virus (EBOV) infection: therapeutic strategies. Biochem. Pharmacol. 93 (2015), 1–10.
45. 45•• Delang, L., Li, C., Tas, A., Quérat, G., Albulescu, I.C., De Burghgraeve, T., Guerrero, N.A.S., Gigante, A., Piorkowski, G., Decroly, E., et al. The viral capping enzyme nsP1: a novel target for the inhibition of chikungunya virus infection. Sci. Rep., 6, 2016, 31819 The first demonstration of the alphavirus guanylyltransferase as a potent target for drug discovery. Novel class of anti-chikungunya compounds is presented, together with the assays described in Ref. [18].
46. Ogino, T., Yadav, S.P., Banerjee, A.K., Histidine-mediated RNA transfer to GDP for unique mRNA capping by vesicular stomatitis virus RNA polymerase. Proc. Natl. Acad. Sci. U. S. A. 107 (2010), 3463–3468.
47. 47•• Liang, B., Li, Z., Jenni, S., Rahmeh, A.A., Morin, B.M., Grant, T., Grigorieff, N., Harrison, S.C., Whelan, S.P.J., Structure of the L protein of vesicular stomatitis virus from electron cryomicroscopy. Cell 162 (2015), 314–327 First long awaited “high resolution” structure (according to Cryo-EM standards) of a L protein from a NNS virus, uncovering how RdRp and capping enzymes are spatially organized and putatively co-ordinated.
48. Métifiot, M., Marchand, C., Pommier, Y., HIV integrase inhibitors: 20-year landmark and challenges. Adv. Pharmacol. San Diego Calif. 67 (2013), 75–105.
49. Guilligay, D., Tarendeau, F., Resa-Infante, P., Coloma, R., Crepin, T., Sehr, P., Lewis, J., Ruigrok, R.W.H., Ortin, J., Hart, D.J., et al. The structural basis for cap binding by influenza virus polymerase subunit PB2. Nat. Struct. Mol. Biol. 15 (2008), 500–506.
50. Xie, L., Wartchow, C., Shia, S., Uehara, K., Steffek, M., Warne, R., Sutton, J., Muiru, G.T., Leonard, V.H.J., Bussiere, D.E., et al. Molecular basis of mRNA cap recognition by influenza B polymerase PB2 subunit. J. Biol. Chem. 291 (2016), 363–370.
51. Stevaert, A., Naesens, L., The influenza virus polymerase complex: an update on its structure, functions, and significance for antiviral drug design. Med. Res. Rev. 36 (2016), 1127–1173.
52. Hooker, L., Sully, R., Handa, B., Ono, N., Koyano, H., Klumpp, K., Quantitative analysis of influenza virus RNP interaction with RNA cap structures and comparison to human cap binding protein eIF4E. Biochemistry (Moscow) 42 (2003), 6234–6240.
53. Clark, M.P., Ledeboer, M.W., Davies, I., Byrn, R.A., Jones, S.M., Perola, E., Tsai, A., Jacobs, M., Nti-Addae, K., Bandarage, U.K., et al. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2. J. Med. Chem. 57 (2014), 6668–6678.
54. Aouadi, W., Blanjoie, A., Vasseur, J.-J., Debart, F., Canard, B., Decroly, E., Binding of the methyl donor S-adenosyl-L-methionine to middle east respiratory syndrome coronavirus 2′-O-methyltransferase nsp16 promotes recruitment of the allosteric activator nsp10. J. Virol., 91, 2017.
55. Parker, W.B., Metabolism and antiviral activity of ribavirin. Virus Res. 107 (2005), 165–171.
56. Paeshuyse, J., Dallmeier, K., Neyts, J., Ribavirin for the treatment of chronic hepatitis C virus infection: a review of the proposed mechanisms of action. Curr. Opin. Virol. 1 (2011), 590–598.
57. Bullard, K.M., Gullberg, R.C., Soltani, E., Steel, J.J., Geiss, B.J., Keenan, S.M., Murine efficacy and pharmacokinetic evaluation of the flaviviral NS5 capping enzyme 2-thioxothiazolidin-4-one inhibitor BG-323. PLoS One, 10, 2015, e0130083.
58. Benarroch, D., Egloff, M.-P., Mulard, L., Guerreiro, C., Romette, J.-L., Canard, B., A structural basis for the inhibition of the NS5 dengue virus mRNA 2′-O-methyltransferase domain by ribavirin 5′-triphosphate. J. Biol. Chem. 279 (2004), 35638–35643.
59. Benmansour, F., Trist, I., Coutard, B., Decroly, E., Querat, G., Brancale, A., Barral, K., Discovery of novel dengue virus NS5 methyltransferase non-nucleoside inhibitors by fragment-based drug design. Eur. J. Med. Chem. 125 (2017), 865–880.
60. Brecher, M., Chen, H., Li, Z., Banavali, N.K., Jones, S.A., Zhang, J., Kramer, L.D., Li, H., Identification and characterization of novel broad-spectrum inhibitors of the flavivirus methyltransferase. ACS Infect. Dis. 1 (2015), 340–349.